Botanical species · safety record

Brassica napus

The EFSA Compendium of Botanicals holds 1 constituent measurement and 1 adverse-effect record for Brassica napus. This page reports what those source records contain and how to reach them. It carries no effect estimate, no dose and no recommendation.

Accepted name in source: Brassica napus L.

1Constituent measurements
1Safety records
2Cited sources
10Licensed products (Canada)

Regulatory presence

Health Canada's Licensed Natural Health Products Database holds 10 licensed products naming Brassica napus as a medicinal ingredient, matched on the exact Latin binomial. A licence records that a product met the regulator's requirements for sale in Canada. It is not evidence that the product works.

Source material stated

  • Bean
  • Brassica napus - Seed
  • Oil
  • Pollen
  • Seed oil
  • Seed(s)

What the records describe

Constituents measured

  • Glucosinolates1

Plant parts

  • Live plants2

Preparations

  • Fresh1
  • Solvent extraction1

Effect types

  • Reproductive1

Target tissues

  • Urogenital1

Recorded constituents

What analytical work has found in this species, at which plant part and preparation. A measured constituent is a fact about material, not about effect.

SubstancePlant partPreparationConcentrationAnalytical methodSource
GlucosinolatesLive plantsSolvent extractionUnspecifiedNo resolvable identifier

Recorded adverse effects

Adverse effects reported in the source literature, most often in animal or laboratory models at a stated preparation and dose.

EffectTarget tissuePlant partPreparationTest organismTest typeSource
ReproductiveUrogenitalLive plantsFreshCattle (as animal)Reproduction toxicityResolve DOI

Cited sources

The literature the compendium cites for this species. Metatron Health has no relationship with these authors or journals and earns nothing from citing them.

  1. BARNOUIN, J., CHALUS, T., LESCOURRET, F. INCREASED PERINATAL FRENCH DAIRY CALF MORTALITY ASSOCIATED WITH FRESH RAPE IN THE PREPARTUM DIET . Preventive veterinary medicine, 1992, vol. 12, no. 1-2, p. 111-120. DOI
  2. Baasanjav-Gerber, Chimgee., Hollnagel, Heli Miriam., Brauchmann, Jana., Iori, Renato., Glatt, Hansruedi. Detection of genotoxicants in Brassicales using endogenous DNA as a surrogate target and adducts determined by 32P-postlabelling as an experimental end point. Mutagenesis, 2011, vol. 26, no. 3, p. 407-413.

Boundary

A constituent measurement is a fact about material at a stated preparation, not a statement about what that material does in a person. An adverse-effect or genotoxicity record is an observation reported in a source, most often in an animal or laboratory model. Neither is a Metatron Health conclusion about causality, human risk or benefit, and the absence of a record is not proof that a preparation is safe. Nothing here is diagnosis, prescribing or individual medical care.

Continue